Table II.
LMTK3 protein levels and clinical features in thyroid cancer.
| Clinical pathological feature | No. | Mean ± SEM | t-value | P-value |
|---|---|---|---|---|
| Gender | −0.713 | 0.48 | ||
| Male | 26 | 0.68±0.06 | ||
| Female | 80 | 0.62±0.01 | ||
| Age (years) | −0.866 | 0.389 | ||
| ≥50 | 37 | 0.67±0.05 | ||
| <50 | 69 | 0.61±0.03 | ||
| Tumour size | −0.465 | 0.643 | ||
| <2 cm | 54 | 0.61±0.04 | ||
| ≥2 cm | 52 | 0.65±0.02 | ||
| Lymph node metastasis | −0.318 | 0.752 | ||
| Negative | 78 | 0.62±0.48 | ||
| Positive | 28 | 0.65±0.35 | ||
| Stage | −4.805 | 0.0001 | ||
| I+II | 89 | 0.54±0.09 | ||
| III+IV | 17 | 0.95±0.10 | ||
| Patdological types | 0.0001 | |||
| Papillary cancer | 68 | 0.44±0.01 | ||
| Follicular cancer | 23 | 0.96±0.06 | ||
| Medullary cancer | 12 | 0.86±0.03 | ||
| Undifferentiated cancer | 3 | 1.17±0.01 |
SEM, standard error of tde mean.